Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 4 | 2020 | 422 | 1.090 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 595 | 0.890 |
Why?
|
| Internship and Residency | 2 | 2018 | 317 | 0.830 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2019 | 17 | 0.640 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 212 | 0.630 |
Why?
|
| Medical Oncology | 2 | 2020 | 90 | 0.630 |
Why?
|
| Tibial Nerve | 1 | 2020 | 19 | 0.620 |
Why?
|
| Taxoids | 1 | 2020 | 50 | 0.610 |
Why?
|
| Sural Nerve | 1 | 2020 | 25 | 0.610 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2019 | 5 | 0.600 |
Why?
|
| Median Nerve | 1 | 2020 | 50 | 0.600 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2019 | 9 | 0.600 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2020 | 52 | 0.600 |
Why?
|
| Mouth Neoplasms | 1 | 2019 | 17 | 0.600 |
Why?
|
| Communication | 1 | 2020 | 129 | 0.590 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 179 | 0.570 |
Why?
|
| Teaching | 1 | 2018 | 60 | 0.550 |
Why?
|
| Ultrasonography | 1 | 2020 | 394 | 0.530 |
Why?
|
| Internal Medicine | 1 | 2017 | 53 | 0.500 |
Why?
|
| Sulfides | 1 | 2016 | 27 | 0.490 |
Why?
|
| Caprylates | 1 | 2016 | 27 | 0.490 |
Why?
|
| Curriculum | 1 | 2017 | 203 | 0.450 |
Why?
|
| Physicians | 1 | 2017 | 163 | 0.440 |
Why?
|
| Lung | 1 | 2016 | 263 | 0.430 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 317 | 0.410 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 764 | 0.400 |
Why?
|
| Neoplasms | 2 | 2018 | 762 | 0.370 |
Why?
|
| Humans | 13 | 2020 | 32286 | 0.280 |
Why?
|
| Pilot Projects | 2 | 2020 | 555 | 0.250 |
Why?
|
| Aged | 6 | 2020 | 10259 | 0.230 |
Why?
|
| Weight Loss | 1 | 2008 | 410 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2020 | 636 | 0.210 |
Why?
|
| Male | 8 | 2020 | 19448 | 0.180 |
Why?
|
| Middle Aged | 6 | 2020 | 11848 | 0.170 |
Why?
|
| Reference Standards | 1 | 2020 | 28 | 0.160 |
Why?
|
| Albumins | 1 | 2020 | 42 | 0.160 |
Why?
|
| Ankle | 1 | 2020 | 28 | 0.160 |
Why?
|
| Epidermis | 1 | 2020 | 29 | 0.160 |
Why?
|
| Forearm | 1 | 2020 | 44 | 0.150 |
Why?
|
| Electrodiagnosis | 1 | 2020 | 41 | 0.150 |
Why?
|
| Nerve Fibers | 1 | 2020 | 38 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2020 | 82 | 0.150 |
Why?
|
| Wrist | 1 | 2020 | 44 | 0.150 |
Why?
|
| Microglia | 1 | 2020 | 67 | 0.150 |
Why?
|
| Paclitaxel | 1 | 2020 | 57 | 0.150 |
Why?
|
| Hypopharyngeal Neoplasms | 1 | 2019 | 7 | 0.150 |
Why?
|
| Leg | 1 | 2020 | 67 | 0.150 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 15 | 0.150 |
Why?
|
| Neural Conduction | 1 | 2020 | 82 | 0.150 |
Why?
|
| Laryngeal Neoplasms | 1 | 2019 | 16 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 1438 | 0.150 |
Why?
|
| Papillomaviridae | 1 | 2019 | 23 | 0.150 |
Why?
|
| Cranial Irradiation | 1 | 2019 | 94 | 0.140 |
Why?
|
| Risk | 1 | 2019 | 305 | 0.140 |
Why?
|
| Female | 7 | 2020 | 19955 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 727 | 0.140 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 42 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 70 | 0.140 |
Why?
|
| Nicotine | 1 | 2020 | 164 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 46 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 156 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2018 | 91 | 0.130 |
Why?
|
| Energy Intake | 2 | 2008 | 122 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 183 | 0.130 |
Why?
|
| Topotecan | 1 | 2016 | 14 | 0.120 |
Why?
|
| Education, Medical | 1 | 2017 | 69 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2017 | 113 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 821 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2018 | 329 | 0.120 |
Why?
|
| Adult | 5 | 2019 | 9263 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1485 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2020 | 2317 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 372 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 442 | 0.100 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 221 | 0.070 |
Why?
|
| United States | 1 | 2017 | 4077 | 0.070 |
Why?
|
| Agaricales | 1 | 2007 | 1 | 0.070 |
Why?
|
| Meat | 1 | 2007 | 16 | 0.070 |
Why?
|
| Baltimore | 1 | 2008 | 50 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2007 | 99 | 0.060 |
Why?
|
| Overweight | 1 | 2007 | 252 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 245 | 0.060 |
Why?
|
| Adolescent | 2 | 2008 | 3519 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 3899 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3612 | 0.040 |
Why?
|
| Chemokine CCL20 | 1 | 2020 | 6 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 24 | 0.040 |
Why?
|
| Obesity | 1 | 2007 | 1111 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2020 | 27 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2008 | 3409 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 196 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2020 | 85 | 0.040 |
Why?
|
| Cell Transformation, Viral | 1 | 2019 | 9 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 285 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 146 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 61 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 458 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 773 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 955 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1529 | 0.030 |
Why?
|
| Mice | 1 | 2020 | 2571 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 1840 | 0.030 |
Why?
|
| Animals | 1 | 2020 | 8197 | 0.020 |
Why?
|
| Satiety Response | 1 | 2007 | 1 | 0.020 |
Why?
|
| Thinness | 1 | 2007 | 32 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 96 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 471 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2007 | 154 | 0.020 |
Why?
|